# OnCo record lyvgen-biopharma (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/lyvgen-biopharma/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "lyvgen-biopharma" ;
  schema:name "Lyvgen Biopharma"@en ;
  schema:alternateName "Lyvgen Biopharma Holdings"@en, "礼进生物"@en ;
  schema:description "Lyvgen Biopharma is a Shanghai antibody company that builds agonists of immune-activating receptors such as CD137 and CD40; its CD137 antibody LVGN6051 is being tested with PD-1 blockade."@en ;
  schema:url <https://onco.cc/companies/lyvgen-biopharma/>, <https://www.lyvgen.com/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://www.lyvgen.com/> ;
  onco:tag "drug-maker" ;
  schema:addressCountry "CN" ;
  onco:drugs <https://onco.cc/drugs/lvgn6051/> .